Primard C, Monchâtre-Leroy E, Del Campo J, et al. Front Immunol. 2023;14:1188605. doi:10.3389/fimmu.2023.1188605
- October 12, 2023
OVX033, a nucleocapsid-based vaccine candidate, provides broad-spectrum protection against SARS-CoV-2 variants in a hamster challenge model
Share on linkedin
Share on reddit
Share on facebook
Share on twitter
Share on email